Twin Tree Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.1M Sell
1,200
-29,900
-96% -$30.3M 0.02% 693
2025
Q4
$33.4M Sell
31,100
-76,300
-71% -$73M 0.29% 56
2025
Q3
$81.9M Buy
107,400
+49,800
+86% +$37.1M 0.34% 38
2025
Q2
$44.9M Buy
57,600
+48,300
+519% +$37.5M 0.08% 236
2025
Q1
$7.68M Sell
9,300
-79,300
-90% -$66M 0.01% 758
2024
Q4
$68.4M Sell
88,600
-198,500
-69% -$164M 0.12% 140
2024
Q3
$254M Buy
287,100
+230,300
+405% +$207M 0.5% 22
2024
Q2
$51.4M Buy
56,800
+45,400
+398% +$36.3M 0.12% 164
2024
Q1
$8.87M Sell
11,400
-33,200
-74% -$23.6M 0.02% 679
2023
Q4
$26M Buy
44,600
+8,500
+24% +$4.96M 0.05% 385
2023
Q3
$19.4M Buy
+36,100
New +$18.6M 0.04% 365
2023
Q1
Sell
-7,400
Closed -$2.71M 1437
2022
Q4
$2.71M Sell
7,400
-103,300
-93% -$36.6M 0.01% 873
2022
Q3
$35.8M Buy
+110,700
New +$35.1M 0.07% 236
2022
Q2
Sell
-213,400
Closed -$61.1M 1702
2022
Q1
$61.1M Sell
213,400
-303,600
-59% -$78.1M 0.1% 150
2021
Q4
$143M Buy
517,000
+110,300
+27% +$28M 0.3% 37
2021
Q3
$94M Sell
406,700
-142,800
-26% -$35.2M 0.21% 82
2021
Q2
$126M Sell
549,500
-103,100
-16% -$20.7M 0.34% 42
2021
Q1
$122M Buy
+652,600
New +$128M 0.46% 36
2020
Q4
Sell
-500
Closed -$74K 1392
2020
Q3
$74K Sell
500
-19,500
-98% -$3.02M ﹤0.01% 1084
2020
Q2
$3.28M Sell
20,000
-23,200
-54% -$3.56M 0.01% 758
2020
Q1
$5.99M Sell
43,200
-617,500
-93% -$84.8M 0.03% 439
2019
Q4
$86.8M Buy
660,700
+570,100
+629% +$66.1M 0.3% 55
2019
Q3
$10.1M Buy
90,600
+45,600
+101% +$5.08M 0.04% 324
2019
Q2
$4.99M Buy
45,000
+41,700
+1,264% +$4.91M 0.02% 455
2019
Q1
$428K Buy
+3,300
New +$401K ﹤0.01% 976
2018
Q4
Sell
-52,600
Closed -$5.64M 1437
2018
Q3
$5.64M Buy
+52,600
New +$5.26M 0.04% 370
2017
Q2
Sell
-179,200
Closed -$15.1M 1072
2017
Q1
$15.1M Sell
179,200
-687,300
-79% -$55M 0.14% 150
2016
Q4
$63.7M Buy
866,500
+738,400
+576% +$55M 0.62% 21
2016
Q3
$10.3M Buy
128,100
+97,700
+321% +$7.82M 0.13% 161
2016
Q2
$2.39M Sell
30,400
-65,100
-68% -$4.9M 0.04% 436
2016
Q1
$6.88M Buy
95,500
+2,800
+3% +$212K 0.13% 169
2015
Q4
$7.81M Buy
92,700
+48,800
+111% +$4.05M 0.15% 129
2015
Q3
$3.67M Buy
43,900
+28,800
+191% +$2.43M 0.09% 204
2015
Q2
$1.26M Buy
15,100
+700
+5% +$53.3K 0.03% 557
2015
Q1
$1.05M Sell
14,400
-8,500
-37% -$605K 0.03% 576
2014
Q4
$1.58M Sell
22,900
-80,800
-78% -$5.45M 0.04% 453
2014
Q3
$6.72M Buy
103,700
+64,700
+166% +$4.1M 0.18% 111
2014
Q2
$2.42M Sell
39,000
-800
-2% -$47.7K 0.05% 358
2014
Q1
$2.34M Sell
39,800
-19,100
-32% -$1.07M 0.05% 412
2013
Q4
$3M Sell
58,900
-11,200
-16% -$561K 0.07% 302
2013
Q3
$3.53M Buy
70,100
+6,400
+10% +$335K 0.12% 184
2013
Q2
$3.13M Buy
+63,700
New +$3.47M 0.12% 188

Other funds holding LLY

Twin Tree Management's LLY Position: Q4 2025 in Review

Twin Tree Management sold out of Eli Lilly (LLY) in Q4 2025, closing a stake of 16,206 shares — an estimated $15.5M sold.

Twin Tree Management first reported a position in LLY in Q2 2013 and held it in 33 quarters. The position peaked at $48.3M in Q3 2024. 4,428 funds tracked by Wall St. Rank hold LLY as of Q4 2025.

  • Twin Tree Management reported no remaining Eli Lilly position as of Q4 2025 after selling out during the quarter.
  • Twin Tree Management sold 16,206 Eli Lilly shares in Q4 2025, an estimated $15.5M.
  • Twin Tree Management first reported a position in Eli Lilly in Q2 2013 and held it in 33 quarters.
  • Twin Tree Management's Eli Lilly position peaked at $48.3M in Q3 2024.
  • 4,428 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2025.

Based on Twin Tree Management's 13F filing for Q4 2025, filed 11 Feb 2026.